nitroglycerin has been researched along with h 89 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujimoto, S; Satake, N; Shibata, S | 1 |
Bettaieb, A; Boina-Ali, R; Cortier, M; Jeannin, JF; Paul, C; Racoeur, C; Solary, E | 1 |
2 other study(ies) available for nitroglycerin and h 89
Article | Year |
---|---|
The potentiation of nitroglycerin-induced relaxation by PKG inhibition in rat aortic rings.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Aorta; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Drug Synergism; Enzyme Inhibitors; In Vitro Techniques; Isoquinolines; Male; Muscle, Smooth, Vascular; Naphthalenes; Nitroglycerin; Potassium Channels; Protein Kinase C; Purinones; Rats; Rats, Wistar; Staurosporine; Sulfonamides; Vasodilator Agents | 1996 |
H89 enhances the sensitivity of cancer cells to glyceryl trinitrate through a purinergic receptor-dependent pathway.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Drug Synergism; Gene Expression Profiling; Humans; Isoquinolines; Membrane Potential, Mitochondrial; Mice; Neoplasms; Nitric Oxide; Nitroglycerin; Oligonucleotides, Antisense; Protein Kinase Inhibitors; Reactive Oxygen Species; Receptors, Purinergic; Receptors, Purinergic P2; Receptors, Purinergic P2X3; Receptors, Purinergic P2Y1; Signal Transduction; Sulfonamides; Transfection | 2015 |